well said Babba. Any double blinded placebo controlled data is highly valuable. In the 5-9 year age stratum, even more so.
It’s more content that will assist our case and give insights into DMOAD action of pps and will give further references to point to for DMOAD label.
Paul has done a lot of heavily lifting, as has others like Ravi (legend) and Queen Donna. And us Retail holders.
Hang in there!
PAR. SP, page-853
-
- There are more pages in this discussion • 299 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.005(2.17%) |
Mkt cap ! $82.20M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 23.5¢ | 23.0¢ | $85.35K | 365.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 280011 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 44703 | 3 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |